Literature DB >> 20643939

Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs.

Diwakar Santhakumar1, Thorsten Forster, Nouf N Laqtom, Rennos Fragkoudis, Paul Dickinson, Cei Abreu-Goodger, Sergei A Manakov, Nila Roy Choudhury, Samantha J Griffiths, Annaleen Vermeulen, Anton J Enright, Bernadette Dutia, Alain Kohl, Peter Ghazal, Amy H Buck.   

Abstract

Although the functional parameters of microRNAs (miRNAs) have been explored in some depth, the roles of these molecules in viral infections remain elusive. Here we report a general method for global analysis of miRNA function that compares the significance of both overexpressing and inhibiting each mouse miRNA on the growth properties of different viruses. Our comparative analysis of representatives of all three herpesvirus subfamilies identified host miRNAs with broad anti- and proviral properties which extend to a single-stranded RNA virus. Specifically, we demonstrate the broad antiviral capacity of miR-199a-3p and illustrate that this individual host-encoded miRNA regulates multiple pathways required and/or activated by viruses, including PI3K/AKT and ERK/MAPK signaling, oxidative stress signaling, and prostaglandin synthesis. Global miRNA expression analysis further demonstrated that the miR-199a/miR-214 cluster is down-regulated in both murine and human cytomegalovirus infection and manifests similar antiviral properties in mouse and human cells. Overall, we report a general strategy for examining the contributions of individual host miRNAs in viral infection and provide evidence that these molecules confer broad inhibitory potential against multiple viruses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20643939      PMCID: PMC2922253          DOI: 10.1073/pnas.1008861107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter.

Authors:  A Angulo; D Kerry; H Huang; E M Borst; A Razinsky; J Wu; U Hobom; M Messerle; P Ghazal
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth.

Authors:  A Angulo; P Ghazal; M Messerle
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 3.  Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus.

Authors:  E A Fortunato; A K McElroy; I Sanchez; D H Spector
Journal:  Trends Microbiol       Date:  2000-03       Impact factor: 17.079

Review 4.  The role of RNAi and microRNAs in animal virus replication and antiviral immunity.

Authors:  Jennifer L Umbach; Bryan R Cullen
Journal:  Genes Dev       Date:  2009-05-15       Impact factor: 11.361

Review 5.  Statistical methods for analysis of high-throughput RNA interference screens.

Authors:  Amanda Birmingham; Laura M Selfors; Thorsten Forster; David Wrobel; Caleb J Kennedy; Emma Shanks; Javier Santoyo-Lopez; Dara J Dunican; Aideen Long; Dermot Kelleher; Queta Smith; Roderick L Beijersbergen; Peter Ghazal; Caroline E Shamu
Journal:  Nat Methods       Date:  2009-08       Impact factor: 28.547

6.  Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling.

Authors:  R A Johnson; X Wang; X L Ma; S M Huong; E S Huang
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection.

Authors:  Robert E Lanford; Elisabeth S Hildebrandt-Eriksen; Andreas Petri; Robert Persson; Morten Lindow; Martin E Munk; Sakari Kauppinen; Henrik Ørum
Journal:  Science       Date:  2009-12-03       Impact factor: 47.728

8.  Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection.

Authors:  Jamel Mankouri; Rennos Fragkoudis; Kathryn H Richards; Laura F Wetherill; Mark Harris; Alain Kohl; Richard M Elliott; Andrew Macdonald
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

9.  Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection.

Authors:  Amy H Buck; Jonathan Perot; Michael A Chisholm; Diwakar S Kumar; Lee Tuddenham; Valérie Cognat; Lisa Marcinowski; Lars Dölken; Sébastien Pfeffer
Journal:  RNA       Date:  2010-01-04       Impact factor: 4.942

10.  Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems.

Authors:  Poornima Parameswaran; Ella Sklan; Courtney Wilkins; Trever Burgon; Melanie A Samuel; Rui Lu; K Mark Ansel; Vigo Heissmeyer; Shirit Einav; William Jackson; Tammy Doukas; Suman Paranjape; Charlotta Polacek; Flavia Barreto dos Santos; Roxana Jalili; Farbod Babrzadeh; Baback Gharizadeh; Dirk Grimm; Mark Kay; Satoshi Koike; Peter Sarnow; Mostafa Ronaghi; Shou-Wei Ding; Eva Harris; Marie Chow; Michael S Diamond; Karla Kirkegaard; Jeffrey S Glenn; Andrew Z Fire
Journal:  PLoS Pathog       Date:  2010-02-12       Impact factor: 6.823

View more
  49 in total

1.  A MicroRNA Screen Identifies the Wnt Signaling Pathway as a Regulator of the Interferon Response during Flavivirus Infection.

Authors:  Jessica L Smith; Sophia Jeng; Shannon K McWeeney; Alec J Hirsch
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection.

Authors:  Thomas J Stark; Justin D Arnold; Deborah H Spector; Gene W Yeo
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

Review 3.  Tinkering with translation: protein synthesis in virus-infected cells.

Authors:  Derek Walsh; Michael B Mathews; Ian Mohr
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

4.  Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.

Authors:  Ravindra Pramod Deshpande; Manas Panigrahi; Chandrasekhar Y B V K; Phanithi Prakash Babu
Journal:  Neurol Sci       Date:  2018-08-08       Impact factor: 3.307

Review 5.  RNAi screening comes of age: improved techniques and complementary approaches.

Authors:  Stephanie E Mohr; Jennifer A Smith; Caroline E Shamu; Ralph A Neumüller; Norbert Perrimon
Journal:  Nat Rev Mol Cell Biol       Date:  2014-09       Impact factor: 94.444

6.  High-Throughput Fluorescence-Based Screen Identifies the Neuronal MicroRNA miR-124 as a Positive Regulator of Alphavirus Infection.

Authors:  Paula López; Erika Girardi; Bryan C Mounce; Amélie Weiss; Béatrice Chane-Woon-Ming; Mélanie Messmer; Pasi Kaukinen; Arnaud Kopp; Diane Bortolamiol-Becet; Ali Fendri; Marco Vignuzzi; Laurent Brino; Sébastien Pfeffer
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

7.  Induction of the cellular microRNA, Hs_154, by West Nile virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors.

Authors:  Jessica L Smith; Finn E Grey; Jennifer L Uhrlaub; Janko Nikolich-Zugich; Alec J Hirsch
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

8.  Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells.

Authors:  Gil Ju Seo; Rodney P Kincaid; Teva Phanaksri; James M Burke; Justin M Pare; Jennifer E Cox; Tien-Ying Hsiang; Robert M Krug; Christopher S Sullivan
Journal:  Cell Host Microbe       Date:  2013-09-26       Impact factor: 21.023

9.  Promotion of Hendra virus replication by microRNA 146a.

Authors:  Cameron R Stewart; Glenn A Marsh; Kristie A Jenkins; Michael P Gantier; Mark L Tizard; Deborah Middleton; John W Lowenthal; Jessica Haining; Leonard Izzard; Tamara J Gough; Celine Deffrasnes; John Stambas; Rachel Robinson; Hans G Heine; Jackie A Pallister; Adam J Foord; Andrew G Bean; Lin-Fa Wang
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

10.  Analysis of circulating human and viral microRNAs in patients with congenital cytomegalovirus infection.

Authors:  Y Kawano; J Kawada; Y Kamiya; M Suzuki; Y Torii; H Kimura; Y Ito
Journal:  J Perinatol       Date:  2016-09-29       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.